Cardiac Arrhythmia Drug Recalled Lawsuit
Recall Affects 1 lot of 225 mg Propafenone Tablets
Oversized Propafenone HCL Tablets Recalled Nationwide
Recall Applies to 225 mg TabletsWatson Pharmaceuticals, Inc., is recalling 1 lot of Propafenone HCL 225 mg Tablets sold in 100 count bottles in the United States because some tablets may contain slightly higher levels of the active ingredient than specified.
The affected lot of Propafenone HCL tablets was shipped to customers between October 15, 2008 and November 26, 2008. The Lot Number is 112680A, and the expiration date is July 31, 2010. No other strengths or lots were affected.
Propafenone is a drug product used to treat cardiac arrhythmias (irregular heartbeats). It has a narrow therapeutic index, so some patients who are particularly sensitive to small variations in dose may experience potentially serious side effects, including arrhythmias (irregular heartbeat) or low blood pressure.
MARCH-24-09: Watson Announces a Nationwide Voluntary Recall of Propafenone HCL Tablets [FDA: PROPAFENONE HCL 225 MGTABLETS RECALLED]
Legal HelpIf you or a loved one has suffered adverse health effects as a result of consuming this product, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Class Action Law Suits
Newsworthy Law Suits
Defective Products Lawsuits
Drug & Medical Claims Lawsuits
Food & Dietary Supplement Lawsuits
Personal Injury Lawsuits
Real Estate Lawsuits
Investment Fraud Lawsuits